Toward AI foundation models for epidemics: Promise, challenges, and paths forward
Proceedings of the National Academy of Sciences · 31.03.2026 · 123 (13)
DOI: 10.1073/pnas.2526192123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.03.2026. Verfasst von Max S Y Lau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322. Hauptthemen laut MEDLINE: COVID-19, Artificial Intelligence, Epidemics, Epidemiological Models. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
Foundation models—large AI systems pretrained on broad, heterogeneous data—are transforming scientific discovery. These models (e.g., GPT, GenCast, AlphaFold) excel at learning generalizable representations and adapting to new tasks with limited data. Yet, epidemic modeling has not experienced a comparable transformation. Traditional models remain pathogen-specific and often struggle to generate rapid insights during emerging outbreaks, as starkly illustrated by the SARS-CoV-2 pandemic. This Perspective asks whether the foundation model paradigm can extend to epidemic science: Can we build a single, pretrained model that captures the shared principles of infectious disease dynamics across pathogens, populations, and settings? Such a model could be fine-tuned to new contexts with minimal data, enabling faster forecasting, inference, and response, especially valuable in resource-limited settings. We argue that the growing convergence of epidemiological insight and modern AI makes this goal both urgent and increasingly plausible. We outline the main challenges in building foundation models for epidemics—nonstationarity, fragmented surveillance data, presence of diverse dynamical regimes, and the need for interpretability. We then propose a roadmap toward epidemic foundation models, emphasizing both algorithmic innovations to address these challenges and progress beyond algorithms, including investments in open datasets and cross-disciplinary training and collaboration. Developing epidemic foundation models offers a potentially transformative opportunity to strengthen global health security, particularly by improving preparedness in underresourced settings. If successful, they will serve as powerful, generalizable tools that complement existing efforts. The process of building these models will itself be valuable, exposing critical data gaps and guiding investments in global surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322.
- Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544.
- Department of Computer Science, Emory University, Atlanta, GA 30322.
ORCID-Profile: Max S Y Lau, C Jessica E Metcalf
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Lau, M. S. Y., Metcalf, C. J. E., Liu, Z., Grenfell, B. T., & Jin, W. (2026). Toward AI foundation models for epidemics: Promise, challenges, and paths forward. Proceedings of the National Academy of Sciences, 123(13). https://doi.org/10.1073/pnas.2526192123
Vancouver
Lau MSY, Metcalf CJE, Liu Z, Grenfell BT, Jin W. Toward AI foundation models for epidemics: Promise, challenges, and paths forward. Proceedings of the National Academy of Sciences. 2026;123(13). doi:10.1073/pnas.2526192123
BibTeX
@article{Lau2026,
author = {Lau, Max S Y and Metcalf, C Jessica E and Liu, Zewen and Grenfell, Bryan T and Jin, Wei},
title = {Toward AI foundation models for epidemics: Promise, challenges, and paths forward},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {13},
doi = {10.1073/pnas.2526192123}
}
EUVIMED